Expression of toll-like receptor 4 in glomerular endothelial cells under diabetic conditions

Acta Histochemica et Cytochemica

Volumn 46, Issue 1, 2013, Pages 35-42

  Takata, Shunsuke ^a   Sawa, Yoshihiko ^a   Uchiyama, Takanobu ^a   Ishikawa, Hiroyuki ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Diabetes; Glomerular endothelial cells; KK TaJcl; Streptozotocin; Toll like receptor 4

Indexed keywords

EID: 84874599065     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.13002     Document Type: Article

References (30)

1. Amano, I., Imaizumi, Y., Kaji, C., Kojima, H. and Sawa, Y. (2011) Expression of podoplanin and classical cadherins in salivary gland epithelial cells of klotho-deficient mice. Acta Histochem. Cytochem. 44; 267-276.
2. Antonetti, D. A., Klein, R. and Gardner, T. W. (2012) Mechanisms of disease: Diabetic retinopathy. N. Engl. J. Med. 366; 1227-1239.
3. Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H. and Jialal, I. (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57; 3090- 3098.
4. Dasu, M. R., Devaraj, S., Park, S. and Jialal, I. (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33; 861-868.
5. Devaraj, S., Dasu, M. R., Rockwood, J., Winter, W., Griffen, S. C. and Jialal, I. (2008) Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J. Clin. Endocrinol. Metab. 93; 578-583.
6. Devaraj, S., Dasu, M. R., Park, S. H. and Jialal, I. (2009) Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52; 1665-1668.
7. Devaraj, S., Jialal, I., Yun, J. M. and Bremer, A. (2011) Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 60; 256-259.
8. Devaraj, S., Tobias, P. and Jialal, I. (2011) Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 55; 441-445.
9. Forbes, J. M., Cooper, M. E., Oldfield, M. D. and Thomas, M. C. (2003) Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14; S254-S258.
10. Haneda, M., Koya, D., Isono, M. and Kikkawa, R. (2003) Overview of glucose signaling in mesangial cells in diabetic nephropathy. J. Am. Soc. Nephrol. 14; 1374-1382.
11. Hata, M., Amano, I., Tsuruga, E., Kojima, H. and Sawa, Y. (2010) Immunoelectron microscopic study of podoplanin localization in mouse salivary gland myoepithelium. Acta Histochem. Cytochem. 43; 77-82.
12. Imaizumi, Y., Amano, I., Tsuruga, E., Kojima, H. and Sawa, Y. (2010) Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs. Acta Histochem. Cytochem. 43; 115-121.
13. Kaji, C., Tsujimoto, Y., Kaneko, M. K., Kato, Y. and Sawa, Y. (2012) Immunohistochemical examination of novel rat monoclonal antibodies against mouse and human podoplanin. Acta Histochem. Cytochem. 45; 227-237.
14. Kaur, H., Chien, A. and Jialal, I. (2012) Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am. J. Physiol. Renal Physiol. 303; F1145-1150.
15. Kawai, T. and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11; 373-384.
16. Kiguchi, S., Imamura, T., Ichikawa, K. and Kojima, M. (2004) Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin. Exp. Pharmacol. Physiol. 31; 57-64.
17. Lin, M., Yiu, W. H., Wu, H. J., Chan, L. Y., Leung, J. C., Au, W. S., Chan, K. W., Lai, K. N. and Tang, S. C. (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J. Am. Soc. Nephrol. 23; 86-102.
18. Mason, R. M. and Wahab, N. A. (2003) Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14; 1358-1373.
19. Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M. and Goetz, F. C. (1984) Structural functional relationships in diabetic nephropathy. J. Clin. Invest. 74; 1143- 1155.
20. Mohammad, M. K., Morran, M., Slotterbeck, B., Leaman, D. W., Sun, Y., Grafenstein, H., Hong, S. C. and McInerney, M. F. (2006) Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int. Immunol. 18; 1101-1113.
21. Noda, Y., Amano, I., Hata, M., Kojima, H. and Sawa, Y. (2010) Immunohistochemical examination on the distribution of cells expressed lymphatic endotheial marker podoplanin and LYVE-1 in the mouse tongue tissue. Acta Histochem. Cytochem. 43; 61- 68.
22. Phichitrasilp, T., Hondo, E., Rerkamnuaychoke, W., Wakitani, S., Sugiyama, M., Terakawa, J. and Kiso, Y. (2009) Reproductive performance in diabetes mice with a special reference to uterine natural killer cells and placental growth factor. J. Vet. Med. Sci. 71; 519-523.
23. Sherry, C. L., O'Connor, J. C., Kramer, J. M. and Freund, G. G. (2007) Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J. Immunol. 178; 663-670.
24. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H. and Flier, J. S. (2006) TLR4 links innate immunity and fatty acidinduced insulin resistance. J. Clin. Invest. 116; 3015-3025.
25. Steffes, M. W., Osterby, R., Chavers, B. and Mauer, S. M. (1987) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38; 1077-1081.
26. Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21; 335-376.
27. Tsan, M. F. and Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76; 514-519.
28. van Beijnum, J. R., Buurman, W. A. and Griffioen, A. W. (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11; 91-99.
29. Wong, F. S. and Wen, L. (2008) Toll-like receptors and diabetes. Ann. N. Y. Acad. Sci. 1150; 123-132.
30. Yan, S. F., Ramasamy, R. and Schmidt, A. M. (2008) Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 4; 285-293.